BOOKMARK
  • Korean|
  • Chinese|
  • Japanese|
  • Vietnamese
본문내용 바로가기

Aju Business Daily

SEARCH
  • ECONOMY
  • ENTERTAINMENT
  • IT
  • South Korea
  • North Korea
  • WORLD
  • SPORTS
  • LIFESTYLE
  • AUTO MOTIVE
  • OPINION
  • PEOPLE
  • MILITARY
Home > Health > article

British biotech firm Iksuda to receive drug candidate materials from S. Korean partner LegoChem

Lim Chang-won Reporter(cwlim34@ajunews.com) | Posted : May 14, 2020, 14:01 | Updated : May 14, 2020, 14:01
  • 트위터
  • 페이스북
  • 웨이보

[Courtesy of LegoChem Biosciences]


SEOUL -- Iksuda Therapeutics, a British biotech company that develops antibody-drug conjugates, will receive anti-cancer drug candidate materials from LegoChem Biosciences, a biopharmaceutical company in South Korea, for the development of blood cancer treatment.

Antibody-drug conjugates (ADCs) combine the targeting capabilities of monoclonal antibodies with the cancer-killing ability of cytotoxic drugs. LegoChem's proprietary platform enables the design of homogeneous plasma stable ADCs with the potential for improved payload delivery to cancer cells.

Iksuda was given exclusive rights to the global monopoly of ADC anti-cancer drug candidate materials LegoChem has jointly developed with Novimmune, a Swiss pharmaceutical development company. "We will work with Iksuda's clinical development subsidiary in Boston to quickly enter clinical trials," said LegoChem CEO Kim Yong-zu.

In April, Iksuda gained certain rights to LegoChem's ADC technology to develop and commercialize anticancer therapeutics. The South Korean company would receive milestone payments, which are paid when each milestone is achieved in clinical trials and commercialization, as well as royalties on the sales of any resulting ADC products.
 

  • Lim Chang-won Reporter
  • email : cwlim34@ajunews.com
© Aju Business Daily & www.ajunews.com Copyright: All materials on this site may not be reproduced, distributed, transmitted, displayed, published or broadcast without the authorization from the Aju News Corporation.
  • twitter
  • facebook
  • weibo
  • link copy
  • LIST
  • TOP

Related news

  • .Boryung secure exclusive rights to sell nano-particle anticancer drug developed by SN Bioscience.
    Boryung secure exclusive rights to sell nano-particle antica…
  • .GC Labcell exports original technology for U.S. deal to develop cell therapies.
    GC Labcell exports original technology for U.S. deal to deve…
  • .     Chong Kun Dangs COVID-19 drug candidate allowed to complete clinical trials in Russia.
    Chong Kun Dang's COVID-19 drug candidate allowed to com…
  • .Biotech companies selected for state project to establish big data in biology.
    Biotech companies selected for state project to establish bi…
  • .LG deploys autonomous serving robots to medical centers to carry specimens.
    LG deploys autonomous serving robots to medical centers to c…

Real Time Photo News

  • .S. Korea to build state-run K-pop concert hall for unaffordable online performances .

    S. Korea to build state-run K-pop concert hall for unaffordable online performances

  • .BLACKPINK member Rosé to release solo album in March.

    BLACKPINK member Rosé to release solo album in March

  • .BTS agency posts record earnings in 2020 on brisk online activities and album sales .

    BTS agency posts record earnings in 2020 on brisk online activities and album sales

  • .[FOCUS] BTS agency leagues with Universal Music to launch new K-pop band in US music scene.

    [FOCUS] BTS agency leagues with Universal Music to launch new K-pop band in US music scene

  • .CJ ENM aims to become major visual content producer thru partnership with Epic Games .

    CJ ENM aims to become major visual content producer thru partnership with Epic Games

Latest News

more+

  • S. Korea to build state-run K-pop concert hall for unaffordable online performances
  • Busan to set up barrier-free public transportation environments for disabled
  • Hyundai auto group forges hydrogen alliance with SK Group
  • Scuba diving in Cebu cited as most viewed content in LG Uplus VR platform
  • SKT uses VR platform to hold non-face-to-face entrance ceremony for university freshmen
Aju Business Daily
  • ABOUT US
  • CONTACT US
  • PRIVACY STATEMENT
  • Copyright Policy

Address : Aju News Corporation LEEMA Building, 11th floor, 42, Jong-ro 1-gil, Jongno-gu, Seoul.    Mail : swatchsjp@ajunews.com

Copyright ⓒ 2016 By Ajunews Corporation, All Rights Reserved.

Mobile view